These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23613721)

  • 21. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
    Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
    PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More resistance to oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2009 Jan; 51(1304):5-6. PubMed ID: 19172138
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
    Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.
    Okomo-Adhiambo M; Fry AM; Su S; Nguyen HT; Elal AA; Negron E; Hand J; Garten RJ; Barnes J; Xiyan X; Villanueva JM; Gubareva LV;
    Emerg Infect Dis; 2015 Jan; 21(1):136-41. PubMed ID: 25532050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of oseltamivir resistance among human influenza A (H1N1) strains isolated in 2007-2008 flu season].
    Reina J
    Med Clin (Barc); 2008 Jun; 131(2):63-4. PubMed ID: 18588831
    [No Abstract]   [Full Text] [Related]  

  • 26. Oseltamivir- and amantadine-resistant influenza virus A (H1N1).
    Cheng PK; To AP; Leung TW; Leung PC; Lee CW; Lim WW
    Emerg Infect Dis; 2010 Jan; 16(1):155-6. PubMed ID: 20031069
    [No Abstract]   [Full Text] [Related]  

  • 27. Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.
    Yi H; Lee JY; Hong EH; Kim MS; Kwon D; Choi JH; Choi WY; Kim KS; Lee JK; Oh HB; Kang C
    Emerg Infect Dis; 2010 Dec; 16(12):1938-42. PubMed ID: 21122225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
    Ujike M; Ejima M; Anraku A; Shimabukuro K; Obuchi M; Kishida N; Hong X; Takashita E; Fujisaki S; Yamashita K; Horikawa H; Kato Y; Oguchi A; Fujita N; Tashiro M; Odagiri T;
    Emerg Infect Dis; 2011 Mar; 17(3):470-9. PubMed ID: 21392439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.
    Järhult JD; Muradrasoli S; Wahlgren J; Söderström H; Orozovic G; Gunnarsson G; Bröjer C; Latorre-Margalef N; Fick J; Grabic R; Lennerstrand J; Waldenström J; Lundkvist A; Olsen B
    PLoS One; 2011; 6(9):e24742. PubMed ID: 21931841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.
    Hall RJ; Peacey MP; Ralston JC; Bocacao J; Ziki M; Gunn W; Quirk A; Huang QS
    Euro Surveill; 2009 Jul; 14(30):19282. PubMed ID: 19643060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages.
    Janies DA; Voronkin IO; Studer J; Hardman J; Alexandrov BB; Treseder TW; Valson C
    Int J Health Geogr; 2010 Feb; 9():13. PubMed ID: 20181276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in the United Arab Emirates.
    Alfaresi M; Albedwawi S; Hag-Ali M
    Med Princ Pract; 2011; 20(1):97-9. PubMed ID: 21160224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current anti-influenza virus chemotherapy].
    Yoshioka D; Tokimatsu I; Ishii H; Kadota J
    Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection.
    Ozdemir H; Çiftçi E; Ince EU; Ertem M; Ince E; Doğru U
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):135-7. PubMed ID: 21285906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir-resistant seasonal A(H1N1) and A(H1N1)pdm09 influenza viruses from the 2007/2008 to 2012/2013 season in Nara Prefecture, Japan.
    Yoneda M; Okayama A; Kitahori Y
    Jpn J Infect Dis; 2014; 67(5):385-8. PubMed ID: 25241691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.